Cti Biopharma Corp buy Needham & Company LLC
Start price
20.04.23
/
50%
€4.61
Target price
20.04.24
€8.20
Performance (%)
81.37%
End price
21.04.24
-
Summary
This prediction is currently being closed. With a performance of 81.37% the BUY prediction by Needham___Company_LL is a big success. Needham___Company_LL has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y |
---|---|---|---|
Cti Biopharma Corp | - | - | - |
iShares Core DAX® | -0.992% | -3.231% | 11.661% |
iShares Nasdaq 100 | -0.225% | -3.339% | 36.491% |
iShares Nikkei 225® | -0.736% | -7.859% | 18.597% |
iShares S&P 500 | -0.509% | -2.979% | 26.341% |
Comments by Needham___Company_LL for this prediction
In the thread Cti Biopharma Corp diskutieren
CTI BioPharma Corp. (NASDAQ: CTIC) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $9.00 price target on the stock.
Ratings data for CTIC provided by MarketBeat
In the thread Trading Cti Biopharma Corp
Die von Needham___Company_LL gewählte maximale Laufzeit wurde überschritten